Search

Your search keyword '"Cerbelli, Bruna"' showing total 375 results

Search Constraints

Start Over You searched for: Author "Cerbelli, Bruna" Remove constraint Author: "Cerbelli, Bruna"
375 results on '"Cerbelli, Bruna"'

Search Results

1. Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis

2. Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis

4. The role of CD73 in predicting the response to immunotherapy in head and neck cancer patients

6. Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey

7. The evolving landscape of anatomic pathology

9. Ultrasound-guided cryoablation of early breast cancer: safety, technical efficacy, patients' satisfaction, and outcome prediction with MRI/CEM: a pilot case-control study.

11. Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence

12. The 5-Ws of immunotherapy in head and neck cancer

13. Kidney Biopsy and Immuno-Rheumatological Diseases: A Retrospective and Observational Study

14. Clinical and histological features of patients with primary Sjögren's syndrome and autoimmune thyroiditis: a national multicentre cross-sectional study

15. Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era

16. The role of opioids in cancer response to immunotherapy

22. PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey

28. Autophagy occurs in lymphocytes infiltrating Sjögren’s syndrome minor salivary glands and correlates with histological severity of salivary gland lesions

32. Involvement of Substance P (SP) and Its Related NK1 Receptor in Primary Sjögren’s Syndrome (pSS) Pathogenesis

33. Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients

34. Supplementary Data from Kras/ADAM17-Dependent Jag1-ICD Reverse Signaling Sustains Colorectal Cancer Progression and Chemoresistance

35. Abstract P6-10-09: Mutational landscape of breast cancer patients in ROME trial: preliminary results

36. Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey

37. Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma

39. PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey

41. Novel compound mutations in the mitochondrial translation elongation factor (TSFM) gene cause severe cardiomyopathy with myocardial fibro-adipose replacement

43. Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma

44. Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology

45. Circulating CD137+ T cell levels are correlated with response to Pembrolizumab treatment in advanced head and neck cancer patients

46. Evaluating programmed death‐ligand 1 (PD‐L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study

47. The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy

48. Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile

49. RNA‐seq profiling reveals different pathways between remodeled vessels and myocardium in hypertrophic cardiomyopathy

Catalog

Books, media, physical & digital resources